HAN Bao-hui. Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: 5-Year Outcomes From KEYNOTE-189[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 208-212. DOI: 10.12019/j.issn.1671-5144.2023.04.004
|
Citation:
|
HAN Bao-hui. Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: 5-Year Outcomes From KEYNOTE-189[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 208-212. DOI: 10.12019/j.issn.1671-5144.2023.04.004
|
HAN Bao-hui. Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: 5-Year Outcomes From KEYNOTE-189[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 208-212. DOI: 10.12019/j.issn.1671-5144.2023.04.004
|
Citation:
|
HAN Bao-hui. Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: 5-Year Outcomes From KEYNOTE-189[J]. Journal of Evidence-Based Medicine, 2023, 23(4): 208-212. DOI: 10.12019/j.issn.1671-5144.2023.04.004
|
DownLoad: